What is mental illness? toward a neuroscience of humanity Peter C. Whybrow Invited Commentary Pages: 275 - 275
Rapid cycling bipolar disorder: A new treatment option Trisha Suppes Clinical Trials Report Pages: 283 - 284
Blinded 12-month maintenance treatment for bipolar i disorder Trisha Suppes Clinical Trials Report Pages: 284 - 285
Prevalence and description of psychotic features in bipolar mania Eduardo DunayevichPaul E. Keck Jr OriginalPaper Pages: 286 - 290
Atypical antipsychotic drugs in nonschizophrenic psychiatric disorders Carlos A. Zarate JrMeenakshi VemuriMichelle Land OriginalPaper Pages: 291 - 297
Biology and recent brain imaging studies in affective psychoses Po W. WangTerence A. Ketter OriginalPaper Pages: 298 - 304
Evaluation of newer treatment interventions for psychotic depression Brandi L. O’NealChristine L. SmithMadhukar H. Trivedi OriginalPaper Pages: 305 - 309
Current concepts in rapid cycling bipolar disorder Melvin D. SheltonJoseph R. Calabrese OriginalPaper Pages: 310 - 315
Cognitive-Behavioral therapy, imipramine, or their combination for panic disorder Franklin R. Schneier Clinical Trials Report Pages: 325 - 326
Paroxetine in social phobia/social anxiety disorder Franklin R. Schneier Clinical Trials Report Pages: 326 - 326
Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder Lisa D. KochanQureshiBrian A. Fallon OriginalPaper Pages: 327 - 334
Maximizing treatment outcome in post-traumatic stress disorder by combining psychotherapy with pharmacotherapy Randall D. MarshallMarylene Cloitre OriginalPaper Pages: 335 - 340
The cognitive-affective neuroscience of obsessive-compulsive disorder Dan J. SteinWayne K. GoodmanScott L. Rauch OriginalPaper Pages: 341 - 346
Recent developments in child and adolescent social phobia Denise A. ChaviraMurray B. Stein OriginalPaper Pages: 347 - 352
The neurobiology of social phobia: From pharmacotherapy to brain imaging Michael Van AmeringenCatherine ManciniJonathan Oakman OriginalPaper Pages: 358 - 366